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1. Introduction 
Cutaneous drug eruptions are common, with a prevalence of approximately 2 % to 3 % in 
hospitalized patients.[Bigby, 2001, Bigby, et al., 1986] It has been estimated that 1 of every 
1000 hospitalized patients has a serious cutaneous drug reaction.[Roujeau and Stern, 1994] 
In clinical practice, the diagnosis of a cutaneous drug eruption is based on a clinical history 
suggesting that the rash is temporally related to the consumption of a new drug, the gross 
morphology of the rash, and, often, the histopathologic examination of a skin biopsy. The 
diversity of cutaneous drug eruptions is broad.[Kaplan, 1984, Roujeau, 2005, Wintroub and 
Stern, 1985] The vast majority of drug reactions is represented by morbilliform 
(scarlatiniform or rubeoliform) exanthemas (40%).[Gerson, et al., 2008] Followed by urticaria 
and angioedema, they account for up to 95% of cutaneous reactions.[Crowson, et al., 2003, 
Kauppinen and Stubb, 1984, Stubb, et al., 1994] Although generalized and often developing 
fast with some systemic symptoms such as pruritus, burning or shiver, these drug reactions 
are not severe and usually stop rapidly without much intervention after cessation of the 
culprit drug.  
Histopathologically, drug reactions may simulate each of the patterns of inflammatory 
diseases of the skin and subcutaneous fat. However, by far the most common pattern 
evoked by them is “interface dermatitis”.[Ackerman, et al., 2005] That pattern usually is 
joined by an infiltrate that encircles only the venules of the superficial plexus, but, 
episodically, the infiltrate is present around venules of both vascular plexuses. Of the two 
types of interface dermatitis induced by drugs, namely, vacuolar and lichenoid, the vacuolar 
is the most common. 
Severe drug-induced skin reactions include Stevens-Johnson syndrome (SJS) and toxic 
epidermal necrolysis (TEN), moreover, generalized bullous fixed drug eruption (GBFDE), 
acute generalized exanthematous pustulosis (AGEP), and drug reaction with eosinophilia 
and systemic symptoms (DRESS). Furthermore, toxic erythemas after chemotherapy and 
drug-induced linear-IgA-dermatosis should be listed among them. Within the following 
chapter they will be elucidated from a clinical but in particular histopathologic point of 
view.   
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2. Stevens-Johnson syndrome and toxic epidermal necrolysis 
2.1 Clinical presentation 
SJS and TEN are viewed as a single disease entity of different severity.[Bastuji-Garin, et al., 
1993] Both are characterized by a macular confluent erythema evolving into sometimes 
extensive blistering or epidermolysis that resembles a second degree burn (figures 1A and 




       
(b)                                                              (c) 
Fig. 1. A: SJS/TEN, early stage, with confluent erythematous macules, atypical targets and 
localized epidermolysis. The patient later developed more extensive epidermolysis. 
B and C: Normal cornified layer. Dermal, superficial, sparse, perivascular and interstitial 
infiltrate of lymphocytes. Focal vacuolar alteration along the dermoepidermal junction in 
company with some lymphocytes. Focally scattered necrotic keratinocytes throughout the 
lower part of the epidermis. Extravasated erythrocytes. (B: hematoxylin-eosin, original 
magnification x100, C: hematoxylin-eosin, original magnification x400). 
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conjunctiva, and the genitals. The reactions are often accompanied by fever and malaise. SJS is 
characterized by a preference for the trunk or generalized dissemination of rather atypical target 
lesions and maculae. These are confluent and form blisters which may merge. Detachment of 
the skin affects less than 10 % of body surface area. The largest percentage of skin detachment, 
more than 30 %, occurs in TEN with maculae, whereas in the very rare form of TEN with 
widespread erythema the amount of blisters and erosions often affects little more than 10% of 
body surface area. A transitional form called SJS/TEN-overlap has been defined with blisters 
and erosions affecting 10 % to 30 % of body surface area.[Bastuji-Garin, et al., 1993]. 
Whereas SJS, SJS/TEN-overlap and TEN are considered as a single disease of different 
severity, erythema (exsudativum) multiforme majus (EM with mucosal involvement; 
E(E)MM) is different not only in terms of the clinical pattern, but also in terms of etiology. 
Especially shared histologic characteristics lead to the original thinking of a common disease 
spectrum. Typical or atypical raised targets are characteristic for EMM. They appear mainly 
on the limbs, but sometimes also on face and trunk, especially in children. Severe mucosal 
involvement is found in both, EMM and SJS/TEN, and does not allow a differentiation. Skin 
detachment in EMM is usually very limited, since only small blisters appear on the target 
lesions. While the minor and major form of EM are mainly triggered by infectious agents, 
such as acute or recurrent eruptions of herpes simplex, mycoplasma pneumonia, as well as 
other infections of the upper respiratory tract, flu, and flu-like infections, SJS/TEN are 
predominantly caused by drugs. [Auquier-Dunant, et al., 2002] Drugs with a high risk to 
induce SJS/TEN are allopurinol, antibacterial sulfonamides, non-steroidal anti-
inflammatory drugs of the oxicam-type, various antiepileptic drugs, such as carbamazepine, 
lamotrigine, phenobarbital, phenytoin,, and the non-nucleoside reverse-transcriptase 
inhibitor nevirapine. [Mockenhaupt, et al., 2008]) SJS/TEN may end fatally in only a few 
days and mortality is more than 40% in TEN.[Mockenhaupt, 2008, Mockenhaupt and 
Norgauer, 2002] Despite the fact that a diagnosis of EMM and SJS/TEN in most cases can be 
made clinically and histopathologically with confidence, no judgment can be made, on 
morphologic grounds alone, about the cause of it. Moreover, there are currently no in vivo 
or in vitro tests that can identify the causative agent in SJS/TEN with certainty. Thus, 
causality assessment is mainly based on a thorough history of drug exposure and infection 
of the individual patient. 
2.2 Histology 
SJS and TEN share a particular histological pattern.[Ackerman, et al., 2005, Rzany, et al., 
1996] In early erythematous macules, papules, or plaques a sparse to moderate perivascular 
and interstitial infiltrate of lymphocytes is present in the superficial dermis. Occasional 
eosinophilic granulocytes may be found. Vacuolar alteration is found along the 
dermoepidermal junction (DEJ) often in company with some lymphocytes. Necrotic 
keratinocytes are scattered throughout the lower part of the epidermis (figures 1B and 1C). 
Infundibular epidermis and acrosyringia of eccrine ducts may be involved. Slight ballooning 
of keratinocytes and spongiosis may be present. The cornified layer shows a normal basket-
weave configuration. In fully developed stages of the disease, when epidermal 
detachment/epidermolysis appears, in addition to the above mentioned changes 
subepidermal vesiculation secondary to extensive vacuolar alteration and confluent necrosis 
of keratinocytes develops. Confluent necrosis can involve the upper part of infundibular 
epidermis and acrosyringia of eccrine ducts. Variable numbers of extravasated erythrocytes 
are present. As the process develops rapidly, usually neither melanophages nor 
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siderophages are found in the upper part of the dermis. The cornified layer remains 
unchanged (figures 2B, 2C, and 2D). In late hyperpigmented macules and patches a sparse 
superficial perivascular infiltrate of lymphocytes may still be present. Slight vacuolar 
alteration remains at the DEJ. Melanophages are scattered in variable numbers in the 
papillary dermis, optionally together with some siderophages.  Re-epithelialization of the 
epidermis beneath a subepidermal blister can be mentioned. Cornified layer shows slight 
parakeratosis or sometimes scale-crust. In areas of epidermal necrosis and epidermolysis the 
dermis may be covered by a fibrinoid crust containing neutrophilic granulocytes. Some 
neutrophilic granulocytes may also be present in the adjacent dermis.  
 
   
(a)      (b) 
 
(c)      (d) 
Fig. 2. A: Toxic epidermal necrolysis, advanced stage, with confluent erythematous macules, 
atypical targets evolving into large erythema and widespread epidermolysis. 
B and C: Subepidermal vesiculation secondary to extensive vacuolar alteration and 
confluent necrosis of keratinocytes. A dermal, superficial, very sparse, perivascular and 
interstitial infiltrate of lymphocytes. Unchanged cornified layer. (B: hematoxylin-eosin, 
original magnification x40, C: hematoxylin-eosin, original magnification x400)  
D: Changes from the erythematous edge of a blister. Features correspond to early changes 
mentioned in figure 1B and C (hematoxylin-eosin, original magnification x400). 
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                                          (a)                                                              (b) 
  
                                    (c)                                                              (d) 
Fig. 3. A and B: Erythema multiforme with target lesions on the extremities. 
C and D: Subepidermal vesiculation secondary to extensive vacuolar alteration and confluent 
necrosis of keratinocytes. Dermal, superficial, moderate, perivascular and interstitial infiltrate 
of lymphocytes. Unchanged cornified layer. Changes are indistinguishable from those of 
Stevens-Johnson syndrome or toxic epidermal necrolysis. (C: hematoxylin-eosin, original 
magnification x40, D: hematoxylin-eosin, original magnification x200). 
Immunohistochemically, there is a predominance of CD4+ cells in the dermis and CD8+ 
cells in the epidermis similar to graft-versus-host disease (GVHD). Cytotoxic T cells can 
initiate apoptosis, exacerbated by the release of perforins, cytokines such as tumor necrosis 
factor-alpha (TNF-) and FAS-ligand.[Abe, et al., 2003, Chang, et al., 2004, Nassif, et al., 
2004a, Nassif, et al., 2002] Recent findings demonstrate that secretory granulysin is a key 
molecule responsible for the disseminated keratinocyte death in SJS/TEN and highlight a 
mechanism for cytotoxic T lymphocyte- and natural killer cell-mediated cytotoxicity that 
does not require direct cellular contact.[Chung, et al., 2008] Granulysin concentrations in the 
blister fluids were two to four orders of magnitude higher than perforin, granzyme B or 
soluble FAS-ligand concentrations, therewith being the most highly expressed cytotoxic 
molecule.[Chung, et al., 2008] It is also thought that proteins such as FAS-antigen (CD95) 
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and p55-TNF--receptors promote keratinocyte apoptosis.[Abe, et al., 2003, Chang, et al., 
2004, Viard, et al., 1998]  In blister fluid obtained from patients with sulfonamide-induced 
TEN, it has been shown that the lymphocytes were only cytotoxic in the presence of 
cotrimoxazole or sulfamethoxazole, but not toward hydroxylamine metabolites of 
sulfamethoxazole. This is the first sign that lesional T lymphocytes exhibit a direct cytotoxic 
response towards autologous cells without prior re-stimulation.[Nassif, et al., 2004b] In 
addition, ligands such as TRAIL (tumor necrosis factor related apoptosis inducing ligand) 
and TWEAK (TNF-like weak inducer of apoptosis) are secreted by CD1a+ and CD14+ cells 
capable of inducing keratinocyte death in an MHC class I-independent manner, also seem to 
be present in the blister fluids of patients with TEN.[de Araujo, et al., 2011]  
2.3 Differential diagnoses histopathologically 
Erythema (exsudativum) multiforme majus (E(E)MM) and SJS/TEN share a similar 
histology.[Ackerman, et al., 2005, Rzany, et al., 1996] Individual cases may show minor 
differences, but these concern mostly quantitative aspects. The dermal infiltrate in EM, 
SJS/TEN is a superficial and mostly perivascular. However, it decreases with the severity of 
the disease, being intermediate or even dense in the majority of cases of EM and rather 
sparse in TEN.[Rzany, et al., 1996] Erythrocyte extravasation is found more often in 
EM.[Rzany, et al., 1996] Nevertheless, histopathologic differentiation is impossible (figures 
3A, 3B, 3C, and 3D). 
The most important differential diagnoses for SJS/TEN are ‘generalized bullous fixed drug 
eruption’ (GBFDE) and ‘staphylococcal scalded skin syndrome’ (SSSS). The clinical 
presentation of GBFDE differs from SJS/TEN, as described below, and the Nikolsky sign is 
negative on healthy skin in GBFDE. Also in GBFDE and SSSS there may be limited 
involvement of mucous membranes. Histopathologically, differentiation may be hindered 
based on the fact that features of GBFDE show great overlap with those of EM, or SJS/TEN. 
To what extent histopathologic characteristics of localized fixed drug eruption can be 
transferred for GBFDE and therewith being helpful in differentiation from SJS/TEN has not 
yet been clarified. The dermal inflammatory infiltrate in localized fixed drug eruption is 
usually a superficial and deep, perivascular, lymphocytic infiltrate with some eosinophilic 
and neutrophilic granulocytes, the latter being dispersed also interstitially. However, it 
seems that those features are not necessarily present in GBFDE (data based on experience of 
the authors). Unlike the macular confluent exanthema seen in SJS/TEN, in SSSS there is 
widespread erythema sometimes evolving into erythroderma (figure 4A). The Nikolsky sign 
is often positive, but skin detachment is very superficial. SSSS is far less common than 
SJS/TEN and has a variable age distribution with peak incidences in early childhood and in 
adulthood.[Mockenhaupt, et al., 2005] The disease was previously known as pemphigus 
acutus neonatorum Ritter von Rittershain. Histology in SSSS shows acantholytic blistering 
within the stratum granulosum. There is either no or only a sparse superficial lymphocytic 
infiltrate (figures 4B and 4C). In order to determine the level of epidermal separation as 
quickly as possible and differentiate between TEN and SSSS, the Tzanck smear may be used, 
which employs exfoliative cytology of the blister fluid, which is spread on a slide and 
stained with Giemsa. In SSSS, wide epithelial cells with a small nucleus/cytoplasm ratio are 
seen; in TEN, cuboidal cells with a large cell nucleus/cytoplasm ratio are found. Rapid 
histopathologic diagnosis of a cryostat section is certainly more reliable for rapid 
differentiation between SSSS and TEN. In SSSS, the removed roof of the blister demonstrates 
subcorneal separation, while in TEN the separation is deeper, in the stratum spinosum.  
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(b)                                                               (c) 
Fig. 4. A: Staphylococcal scalded skin syndrome with generalized erythema and widespread 
superficial epidermolysis. 
B and C: Acantholytic blistering within the stratum granulosum. Very sparse superficial 
lymphocytic infiltrate (B: hematoxylin-eosin, original magnification x100, C: hematoxylin-
eosin, original magnification x200). 
Further, drug-induced exanthemas which sometimes demonstrate a multiform, target-like 
appearance without mucosal erosions, and which are histopathologically distinct must be 
considered as differential diagnoses. In particular, cyclooxygenase-2 inhibitors are able to 
induce widespread erythematous target-like skin reactions with certain additional symptoms, 
especially dyspnea and facial edema, and often also more widespread dermal edema (figure 
5A).[Ziemer, et al., 2007] The exanthema is not accompanied by mucous membrane 
involvement and usually shows no or only very localized blisters (< 5% of the body surface). 
Histopathologically, biopsy specimens show a normal epidermis. Necrotic keratinocytes are not 
found. In the superficial dermis, there is a sparse perivascular and interstitial lymphocytic 
infiltrate, sometimes accompanied by a few eosinophilic granulocytes (figure 5B). A few 
lymphocytes may be found in the epidermis; which may in some cases focally be detached from 
the underlying skin as a result of severe edema in the papillary dermis.[Ziemer, et al., 2007] 
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Fig. 5. A: Target-like or multiforme-like drug eruption. Extensive, confluent, erythematous-
violaceous, target-like macules cover the entire body. (Reprinted with permission from 
JAMA & Archives) Cutaneous adverse reactions to valdecoxib distinct from Stevens-
Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2007;143(6):711-6. 
Copyright© (2007), American Medical Association. All rights reserved.  
B: Normal epidermis. Note a sparse perivascular and interstitial lymphocytic infiltrate in the 
superficial dermis and a few lymphocytes in the epidermis (hematoxylin-eosin, original 
magnification x40). (Reprinted with permission from JAMA & Archives) Cutaneous adverse 
reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal 
necrolysis. Arch Dermatol. 2007;143(6):711-6. Copyright© (2007), American Medical 
Association. All rights reserved.  
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Another, essentially distinct, severe and potentially fatal condition is ‘drug reaction with 
eosinophilia and systemic symptoms’ (DRESS). Although clinically well characterized, 
histology has not been studied systematically for this disease entity and reported findings 
are not consistent. If necrotic keratinocytes and basal cell vacuolar degeneration 
predominate together with a superficial lymphocytic infiltrate, histologic differentiation 
from SJS/TEN may be problematic. However, if present, necrotic keratinocytes in DRESS 
are scattered solitary within the epidermis, never provoking blister formation or 
epidermolysis (see subchapter 5). 
In some instances differentiation from autoimmune bullous skin disorders may be necessary. 
Although histopathologically usually distinctive, in such cases immunofluorescence should be 
performed. This may be helpful in differentiating bullous drug eruptions from autoimmune-
blistering diseases, such as bullous pemphigoid or pemphigus. In particular this can be of 
importance in diagnosing drug-induced linear-IgA-dermatosis, showing IgA-depositions 
along the basal membrane zone (see subchapter 7). 
In a few further particular situations the diagnosis of SJS/TEN may be complicated to a 
maximum. This is the case in differentiation of SJS/TEN from advanced acute graft-
versus-host disease of the skin and in differentiation of SJS/TEN from some 
manifestations of acute lupus erythematosus. In lupus erythematosus, vacuolar alteration 
of the DEJ and damage to keratinocytes are helpful in establishing diagnosis. Depending 
on the stage of evolution, necrotic keratinocytes can be seen either scattered throughout 
the lower part or in the entire epidermis in lupus erythematosus and SJS/TEN, leading to 
histopathologic misinterpretation. Because of the paucity of the rather superficial 
perivascular lymphocytic infiltrates and less epidermal atrophy, hyperkeratosis, basal 
membrane zone thickening and pigmentary incontinence, especially subacute-cutaneous 
lupus erythematosus and acute cutaneous lupus erythematosus may show considerable 
histopathologic overlap with SJS/TEN. However, the sum of changes and the notice of 
subtle histopathologic findings often allow differentiation [unpublished data from the 
German Registry of Severe Skin Reactions (Dokumentationszentrum schwerer 
Hautreaktionen, dZh), [Rzany, et al., 1996]). The same difficulty concerns clear 
histopathologic distinction of SJS/TEN from acute GVHD, where a morbiliform rash may 
rapidly progress to severe erythema and blisters (figure 6A).  Histologically, in severe 
acute GVHD scattered necrotic keratinocytes predominate in the deeper epidermis. There 
may or may not be an accompanying lymphocytic infiltrate. Apart from a few 
investigations – none of them performed with an essentially necessary clinical correlation 
- considerable histopathologic studies do not exist.[Paquet, et al., 2001] The importance of 
a lymphocytic infiltrate is disputed and may not be compulsary for the diagnosis of 
GVHD.[Snover, 1990] Nevertheless, in GVHD a few eosinophilic granulocytes may be 
found within the infiltrate, a feature rarely observed in SJS/TEN. Moreover, adnexal 
involvement in SJS/TEN seems to be restricted to infundibular epidermis and epithelia of 
acrosyringia, whereas in GVHD lower parts of the hair follicle and epithelia of sebaceous 
glands may be involved (figures 6B and 6C).[Elliott, et al., 1987] 
3. Generalized bullous fixed drug eruption 
3.1 Clinical presentation 
Generalized bullous fixed drug eruption (GBFDE) may be differentiated clinically from 
SJS/TEN.[Kauppinen, 1972] Classically, in GBFDE there are disseminated brownish 
www.intechopen.com
 Skin Biopsy – Perspectives 
 
96
violaceous patches on which flaccid blisters arise. However, some cases present with 





     
(b)                                                        (c) 
Fig. 6. A: Severe acute cutaneous graft-versus-host disease with confluent erythematous 
macules evolving into large erythema and widespread epidermolysis. 
B: Completely lost epidermis due to subepidermal blister formation. Superficial, dermal, 
perivascular and periadnexal infiltrate of lymphocytes and occasionally eosinophilic 
granulocytes. (hematoxylin-eosin, original magnification x40)  
C: Scattered necrotic keratinocytes and vacuolar alteration throughout the lower part of 
eccrine duct in company with lymphocytes. (hematoxylin-eosin, original magnification 
x400). 
Blistering usually affects only a small percentage of body surface area and between the 
large blisters there are sizable areas of intact skin. Erosive mucosal involvement was 
reported as being rare and rather mild. However, recent data show that in 77% of patients 
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with GBFDE mucous membranes were affected with a predominance of genitalia in both 
men (58%) and women (48%).[Mockenhaupt, et al., 2010] Patients usually do not feel sick, 
however, a fever may occur. Most patients report a history of a similar, often local 
reaction (fixed drug eruption).[Mockenhaupt, et al., 2010, Mockenhaupt and Norgauer, 
2002] Nearly always GBFDE develops after re-exposure of the drug, possibly worsening 
with repeated use. This clearly distinguishes GBFDE from SJS/TEN, which generally 
appear during the first cycle of medication use, that is, without prior sensitization. 
Nevertheless, repeated GBFDE events can lead to increasingly widespread detachment of 
the skin and thus to serious disease. The overall mortality in such cases within six weeks 
after the onset of the reaction was reported to be 21%; all but one patient with lethal 
outcome were more than 70 years old.[Mockenhaupt, et al., 2010] Cotrimoxazole has been 
identified as the most common cause of GBFDE.[Mahboob and Haroon, 1998] In the 
recent case series most frequently associated drugs were co-trimoxazole (50%), followed 
by analgesics such as paracetamol (20%) and metamizole (18%).[Mockenhaupt, et al., 
2010] The average duration between beginning of drug use and onset of the disease 
ranged from one day to about five days.[Mockenhaupt, et al., 2010] 
3.2 Histology 
As mentioned above it is still unclear to what extent histopathologic characteristics of 
localized fixed drug eruption are identical with those of GBFDE. Early lesions of localized 
fixed drug eruption show a sparse superficial and usually deep perivascular and 
interstitial mixed-cell infiltrate of lymphocytes with neutrophilic and eosinophilic 
granulocytes scattered interstitially. The papillary dermis may reveal some edema. 
Lymphocytes in company with neutrophilic and/or eosinophilic granulocytes sprinkled 
along the DEJ in conjunction with vacuolar alteration. The epidermis shows slight 
spongiosis and ballooning. Individual necrotic keratinocytes are found in the basal and 
spinous layers. The cornified layer is normal. In fully developed lesions vacuolar 
alteration at the DEJ is more extensive and may eventuate in subepidermal clefts and 
subepidermal vesicles. Spongiosis is more marked with intraepidermal vesicles. Necrotic 
keratinocytes are more numerous and the entire epidermis sometimes becomes necrotic 
(figures 7C and 7D). In late stages a sparse superficial perivascular infiltrate of 
lymphocytes with numerous melanophages remains in the papillary and sometimes 
upper reticular dermis. Melanophages at the base of a thickened papillary dermis in the 
context of a mixed infiltrate of inflammatory cells that includes neutrophils and 
eosinophils and of an epidermis that houses necrotic keratinocytes are a clue to fixed drug 
eruption recurrent at a particular site. [Ackerman, et al., 2005] 
3.3 Differential diagnoses histopathologically 
SJS/TEN displays changes at the DEJ and in the epidermis identical to those of fixed drug 
eruption, but the perivascular infiltrate usually is superficial only and is made up almost 
exclusively of lymphocytes. Eosinophils usually are few, if they are present at all, and 
neutrophils are absent unless confluent necrosis of the epidermis is prominent and attracts 
them chemotactically. Fixed drug eruption, in contrast to SJS/TEN, usually affects the 
venules of the deep as well as the superficial plexus, and the infiltrate of inflammatory cells 
is mixed, consisting of lymphocytes, eosinophils, and neutrophils perivascular, in the 
interstitium, along the DEJ, and in the epidermis.[Ackerman, et al., 2005] 
www.intechopen.com
 Skin Biopsy – Perspectives 
 
98
     
(a)                                                             (b) 
    
(c)                                                                 (d) 
Fig. 7. A and B: Disseminated violaceous patches with flacid blisters on trunk and 
extremities. 
C and D: Superficial, perivascular and interstitial, mixed-cell infiltrate of lymphocytes with 
neutrophilic and eosinophilic granulocytes scattered interstitially also in deeper parts of the 
dermis. Lymphocytes in company with some neutrophilic granulocytes sprinkled along the 
DEJ in conjunction with vacuolar alteration. Epidermis shows slight spongiosis. Individual 
necrotic keratinocytes are found in the basal and spinous layers. (C: hematoxylin-eosin, 
original magnification x100, D: hematoxylin-eosin, original magnification x200). 
4. Acute generalized exanthematous pustulosis 
4.1 Clinical presentation 
In AGEP there is very acute widespread erythema with hundreds of small, flaccid, 
confluent, non-follicular pustules, especially along the skin folds and on the flexor 
surfaces (figure 8A). The reaction rarely involves mucous membranes, and when it does, 
symptoms are mild. Patients have acute fever and neutrophilia on blood tests.[Roujeau,  
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et al., 1991, Sidoroff, et al., 2001] AGEP shows spontaneous resolution in less then 15  
days with characteristic desquamation. The main causes for AGEP are aminopenicillins, 
quinolones, macrolides, diltiazem, and antimalarial drugs such as (hydroxy-)chloroquine. 
Pristinamycine, which is approved for use in selected countries, is associated with a  
high relative risk of AGEP.[Mockenhaupt, et al., 2008, Sidoroff, et al., 2007] The latency 
period between initiation of the drug and onset of the cutaneous reaction is only a few 
days. 
4.2 Histology 
Histology typically shows non-follicular, spongiform, subcorneal and/or intraepidermal 
pustules, sometimes with marked edema of the papillary dermis. The epidermis is 
otherwise normal with an orthokeratotic stratum corneum, housing in foci neutrophilic 
granulocytes. The adjacent dermis shows superficial, perivascular and interstitial 
lymphocytic infiltrates with neutrophilic (figure 8B) and in most instances eosinophilic 
granulocytes.[Burrows and Russell Jones, 1993, Halevy, et al., 2010, Kardaun, et al., 2010a, 
Sidoroff, et al., 2001] Apart from neutrophils a few eosinophilic granulocytes may be found 
within the epidermis. [Sidoroff, 2001] Vasculitis and/or a small number of necrotic 
keratinocytes[Kardaun, et al., 2010a, Sidoroff, et al., 2001] have been reported in a few cases, 
however, such features are not typical for the disease. Moreover, presence of vasculitis could 
not be confirmed in a recent histopathologic study.[Kardaun, et al., 2010a] In summary, 
comparing AGEP and generalized pustular psoriasis, the presence of eosinophils, necrotic 
keratinocytes, a mixed perivascular and interstitial mid-dermal infiltrate and absence of 
tortuous or dilated blood vessels are in favor of AGEP.[Kardaun, et al., 2010a] 
Immunohistology shows neutrophilic leukocytes in subcorneal pustules that are surrounded 
by activated CD4+ and CD8+ T cells. The keratinocytes, as well as T-cells that have migrated 
to the epidermis, express interleukin-8 (IL-8), which attracts neutrophils. Presumably drug-
specific T-cells migrate first, induce blistering, and then recruit neutrophilic 
leukocytes.[Britschgi, et al., 2001, Pichler, et al., 2002] 
4.3 Differential diagnoses histopathologically 
The main clinical differential diagnosis of an acute developing generalized pustular rash 
is acute generalized (exanthematous) pustular psoriasis. The morphology of the pustules 
is indistinguishable in both diseases. For the differentiation of AGEP from pustular 
psoriasis, criteria for histopathologic distinction have been proposed, i.e. papillary edema, 
vasculitis, exocytosis of eosinophils and single-cell necrosis of keratinocytes in AGEP and 
acanthosis and papillomatosis in pustular psoriasis.[Sidoroff, et al., 2001] However, 
acanthosis and papillomatosis are never suspected findings in acute generalized pustular 
psoriasis. Moreover, vasculitis and single-cell necrosis of keratinocytes, have only 
eventually been observed in AGEP. The fact that in patients with AGEP the allele HLA-
DR-B1*07 has been detected, which is also present in psoriasis patients, might explain the 
interaction between T-cells and neutrophilic leukocytes in both diseases.[Britschgi, et al., 
2001, Pichler, et al., 2002] Discrimination is impossible on the basis of histological criteria, 
but rather depending on the clinical course, since AGEP ameliorates rapidly following 
discontinuation of the trigger in contrast to pustular psoriasis that frequently exhibits a 
prolonged course and is characterized by a difficult therapeutic management.[Sidoroff, et 
al., 2001, Ziemer and Böer, 2006].  
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Fig. 8. A: Acute generalized exanthematous pustulosis. Widespread erythema with 
hundreds of small, flaccid, confluent, non-follicular pustules, especially along the groins and 
on the flexor surfaces of the legs. 
B: Subcorneal pustules. The epidermis is slightly acanthotic with an orthokeratotic stratum 
corneum. The adjacent dermis shows superficial, perivascular and interstitial lymphocytic 
infiltrates with some neutrophilic granulocytes. Features are practically indistinguishable 
from acute eruptive lesions in pustular psoriasis (hematoxylin-eosin, original magnification 
x200). 
Histopathologically, subcorneal and intraepidermal pustules are moreover the pathognomic 
feature in IgA-pemphigus.[Harman, et al., 1999] IgA-pemphigus is a rare intraepidermal 
autoimmune disease characterized by tissue-bound and circulating IgA autoantibodies that 
target the desmosomal proteins of the epidermis, mainly desmocollin 1 and desmogleins. 
The main clinical characteristics are erythematous skin lesions with vesiculopustules, 
erosions, crusts and desquamation favoring the trunk, groins, axillas, and proximal 
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extremities (figures 9A and 9B). The average age of onset is approximately 50 years. 
Histological hallmarks of IgA-pemphigus are subcorneal or intraepidermal pustules, and 
neutrophilic infiltration. Scant epidermal acantholysis may be found, however, acantholysis 
is not as characteristic as it is in classic pemphigus (figures 9C and 9D). Finally, histologic 
discrimination of AGEP from IgA-pemphigus is only possible by immunofluorescence. 
Direct immunofluorescence reveals IgA deposits in the intercellular space throughout the 
epidermis, more intense in superficial layers and less intense in lower layers. Nevertheless, 
in some cases IgA autoantibodies do not react with desmogleins or desmocollins.[Niimi, et 
al., 2000] 
 
   
(a)                                                                      (b) 
  
(c)                                                                      (d) 
Fig. 9. A and B: Erythematous plaques with vesiculopustules (in parts with circinar 
arrangement), erosions, crusts and desquamation, on the trunk of a patient with IgA-
pemphigus. 
C and D: Subcorneal pustules and neutrophilic infiltration (subcorneal pustular dermatosis 
type of IgA-pemphigus). Superficial epidermal acantholysis. Dermal superficial mixed cell 
infiltrate with lymphocytes, eosinophilic and neutrophilic granulocytes, with lymphocytes 
and eosinophilic granulocytes being also in blister content (C: hematoxylin-eosin, original 
magnification x100, D: hematoxylin-eosin, original magnification x200). 
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Within the spectrum of intraepidermal neutrophilic dermatoses is subcorneal pustular 
dermatosis of Sneddon and Wilkinson.[Sneddon and Wilkinson, 1956] Sneddon and 
Wilkinson reported a chronic disease with flaccid and aseptic pustules developing 
predominantly on the trunk and in the groins, axillae and submammary areas. However, 
subcorneal pustulosis Sneddon-Wilkinson no longer seems to be considered an authentic 
clinical entity, since under this term unrelated diseases such as pustular psoriasis and IgA-
pemphigus are subsumed.[Ziemer and Böer, 2006] 
Finally, dermatophyte infections may present with intracorneal and intraepidermal pustules 
together with a superficial perivascular lymphocytic infiltrate containing neutrophilic 
granulocytes. Histochemical staining with periodic acid-Schiff (PAS) may be helpful in 
revealing fungi (figures 10A and 10B). 
 
 
   
(a)                                                                    (b) 
Fig. 10. A: Tinea corporis. Intra- and subcorneal as well as intraepidermal pustules together 
with spongiosis and a superficial perivascular lymphocytic infiltrate containing neutrophilic 
granulocytes. Numerous hyphae within the stratum corneum (hematoxylin-eosin, original 
magnification x200). 
B: Numerous intracorneal hyphae (periodic acid-Schiff, original magnification x200). 
5. Hypersensitivity syndrome / drug reaction with eosinophilia and systemic 
symptoms 
5.1 Clinical presentation 
In 1996, Bocquet et al. coined the term ‘drug rash with eosinophilia and systemic 
symptoms’ (DRESS) for a cutaneous adverse drug reactions associated with fever, 
exanthema and facial edema, lymphadenopathy, hematologic abnormalities and organ 
involvement.[Bocquet, et al., 1996] This clinical entity was reported under various names 
including ‘anticonvulsant hypersensitivity syndrome’ (HSS), ‘drug-induced delayed 
multiorgan hypersensitivity syndrome‘ (DIDMOHS) and DIHS (drug-induced 
hypersensitivity syndrome). The clinical presentation of DRESS includes beside 
exanthema (figure 11A), hematologic abnormalities, enlargement of lymph nodes and 
organ involvement.[Bocquet, et al., 1996] The initial exanthema in DRESS may have a 
morbilliform, sometimes target-like appearance, but then often evolves into 
erythroderma. Patients have facial edema, which often is more pronounced in the 
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periorbital region. Sometimes the reaction is accompanied by cheilitis and redness of the 
pharynx and small erosions on the oral mucosa. Most commonly aromatic anti-convulsant 
drugs such as phenytoin, carbamazepine, and phenobarbital as well as allopurinol have 
been reported as triggering DRESS.[Kardaun, et al., 2010b] There are also numerous 
reports of DRESS after administration of minocycline, thalidomide, and sulfonamides. 
[Bocquet, et al., 1996] Furthermore, a variety of other drugs, such as lamotrigine as well as 
valproic acid and non-steroidal anti-inflammatory drugs (NSAIDs) have been associated 
with this clinical entity.[Wolf, et al., 2005a, Wolf, et al., 2005b] It has also been suggested 
that virus reactivation may play an important role in the development of DRESS, and 
possibly also in a recurrent course or persistence of disease.[Kano, et al., 2006] Japanese 
research groups have consistently shown that human herpes virus 6 (HHV-6) reactivation 
can be detected in the vast majority of their patients who meet the criteria for 
DRESS.[Shiohara, et al., 2007, Shiohara, et al., 2006] These authors included HHV-6 
reactivation as a diagnostic criterion and coined the term ‘drug-induced hypersensitivity 
syndrome’ (DHIS). They speculate that patients fulfilling the criteria of DIHS may 
represent those with a more severe form of DRESS.[Shiohara, et al., 2007, Shiohara, et al., 
2006] However, it has still not been conclusively explained whether the reactivation of 
HHV-6 and other members of the human herpes virus family are part of the disease itself 
or whether they are better interpreted as a complication.  
To date, various diagnostic criteria have been identified: maculopapular rash developing 
more than 3 weeks after starting a drug, prolonged clinical symptoms 2 weeks after 
discontinuation of the causative drug, fever (> 38°C), hematological abnormalities such as 
eosinophilia (> 1.5 × 109/l), leukocytosis (>11x109L) and/or the presence of atypical 
lymphocytes in peripheral blood (> 5%), systemic involvement with lymph node 
enlargement and involvement of at least one internal organ such as hepatitis (more than 
twofold increase in transaminase values), interstitial nephritis, interstitial pneumonia,  
and carditis.[Kardaun, et al., 2007, Shiohara, et al., 2007] Along with the previously 
mentioned changes seen in blood work, patients may also experience thrombocytopenia 
and a drop in hemoglobin levels. Pathological liver, kidney, and other laboratory values 
should be present for several days. Lymph node enlargement should be present at a 
minimum of two different sites. In organ manifestations, interstitial inflammation 
(kidney, lung) predominates. Furthermore, joint pain and myositis, including myocarditis 
may occur. 
5.2 Histology 
The skin changes seen in DRESS are highly variable, and so is histology, which has not been 
studied systematically for this disease entity. A variety of histopathologic features has been 
described in patients with DRESS. Histology in many cases shows solitary to many scattered 
necrotic keratinocytes with basal cell vacuolar degeneration and papillary edema.  The 
accompanying lymphocytic infiltrate (drug-specific T-cells also play a role in DRESS) may 
be dense lichenoid with melanophages and some eosinophilc granulocytes, resembling the 
pattern of a lichenoid drug eruption, or very sparse making the findings compatible with 
early features of EM (figure 11B). Dermal edema may be present, but is not necessarily so. 
Sometimes a band-like infiltrate consisting of atypical lymphocytes with epidermotropism is 
noted that resembles mycosis fungoides.[Bocquet, et al., 1996] Furthermore, leukocytoclastic 
vasculitis and pseudolymphomatous histology were described in patients with 
DRESS.[Bocquet, et al., 1996, Chiou, et al., 2008]  
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Fig. 11. A: Generalized erythematous confluent maculo-papules. Detail from the shoulder. 
B: One of the possible histopathologic presentations of DRESS. A confluent zone of 
parakeratosis below a basket-weave cornified layer. Dermal, superficial, sparse, perivascular 
and interstitial infiltrate of lymphocytes. Focal vacuolar alteration along the 
dermoepidermal junction in company with some lymphocytes. Scattered necrotic 
keratinocytes throughout the entire epidermis. Necrotic keratinocytes also along an 
acrosyringium. (hematoxylin-eosin, original magnification x200). 
5.3 Differential diagnoses histopathologically 
As the histopathologic findings in DRESS are very heterogeneous, final diagnosis is mainly 
based on clinical criteria and specific lab values as indicated by the diagnostic score 
published by Kardaun and colleagues. [Kardaun, et al., 2007]. 
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6. Toxic erythemas after chemotherapy 
6.1 Clinical presentation 
Usually toxic erythema after chemotherapy develops on the palms, soles, as well as fingers 
and toes beginning with dysesthesia followed by edema and erythema. Such condition is 
known as palmoplantar erythrodysesthesia (PPE). Fissuring and ulceration develop in 
severe cases, observed in about one third of treated patients, associated with extreme pain, 
impeded walking and grasping.[Fabian, et al., 1990, Lokich and Moore, 1984, Muggia, et al., 
1997, Vogelzang and Ratain, 1985, Zuehlke, 1974] Apart from palms and soles, or rather 
hands and feet in general, lesions may develop on any other skin area. Severe involvement 
has been reported on buttocks[Lopez, et al., 1999] and os sacrum.[Muggia, et al., 1997, 
Uziely, et al., 1995] Further locations are mentioned occasionally. Such changes have been 
reported under different names, to wit, “chemotherapy-induced toxic erythema” or 
intertriginous epidermal dysmaturation”.[English, et al., 2003, Skelton, et al., 2002]  
However, proceeding from the influence of mechanical stress in the pathogenesis of 
palmoplantar erythrodysesthesia and the increased accumulation of the drug in sweat 
glands, involvement of more extensive parts of the body is most likely. Flexural areas are 
predisposed due to lasting influence of friction and dense distribution of sweat glands 
(figures 12A and 12B). Such clinical manifestations are in the spectrum of chemotherapy-
induced epidermal changes, showing identical clinical as well as histopathologic features. 
6.2 Histology 
Despite the numerous publications, histopathologic features have not systematically been 
described. Typical features include a vacuolar degeneration of the basal layer of the 
epidermis together with necrotic keratinocytes and mild spongiosis. Dermal changes may 
include slight papillary edema, dilated blood vessels and a sparse superficial perivascular 
lymphocytic infiltrate.[Nagore, et al., 2000] Other authors described the condition as marked 
by hyperkeratosis.[Comandone, et al., 1993, Gordon, et al., 1995] However, hyperkeratosis is 
not related to the drug reaction but simply explained by the volar location of the lesions. In 
cases of PPE developing on non-volar skin, this feature is not present. Histopathologic 
changes of PPE are indistinguishable from other chemotherapy-induced toxic erythemas 
such as generalized erythema [Hymes, et al., 1985b, Yokel, et al., 1987] or lesions reported as 
“intertriginous epidermal dysmaturation”.[English, et al., 2003] Those conditions show 
similar epidermal changes with vacuolization and necrotic keratinocytes that are disposed 
solitary or in clusters near the junction and sometimes also within the middle and upper 
spinous layers. Often chemotherapeutics cause epidermal maturation disturbances with 
individual enlarged keratinocytes with abnormally large nuclei and prominent nucleoli 
(figure 12 C). 
6.3 Differential diagnoses histopathologically 
Similar changes, however without keratinocyte maturation disturbances, are also present in 
SJS/TEN or fixed drug eruption. Fixed drug eruptions comparatively show a superficial 
perivascular, and interstitial infiltrate that includes eosinophilic and neutrophilic 
granulocytes in most instances. SJS/TEN is best differentiated by clinical impression; 
however, diagnosis might be difficult in early stages. Principally, it is true that similar 
histologic features appear in acute graft-versus-host disease.[Beard, et al., 1993] However, 
graft-versus-host disease is distinguishable, in particular together with the patient’s history 
of stem cell or bone marrow transplantation. 
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(c) 
Fig. 12. A and B: Toxic erythema after chemotherapy with pegylated doxorubicine. 
Confluent erythematous macules to large erythemas with epidermolysis. Severe 
involvement of mechanically stressed areas such as the buttocks, sacrum and elbows. 
C: Vacuolization and necrotic keratinocytes disposed solitary near the junction. Epidermal 
maturation disturbances with individual enlarged keratinocytes with prominent nucleoli 
(hematoxylin-eosin, original magnification x40). 
7. Drug-induced linear-IgA dermatosis 
7.1 Clinical presentation 
Linear IgA dermatosis (LAD) is a rare autoimmune subepidermal blistering disorder. 
Although in most instances idiopathic, LAD may be drug-related. Multiple drugs have been 
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reported to cause LAD, but vancomycin is reported most frequently.[Brinkmeier, et al., 
2003] Classically, LAD shows tense blisters with a linear or annular arrangement on 
erythematous or normal appearing skin (figures 13A and 13B). Sites of predilection are the 
trunk, lower extremities, face, perineum and groins. Mucous membrane involvement, 
reported in idiopathic LAD with about 50%, is observed less often. However, the clinical 
presentations of both idiopathic and drug-related LAD are variable and may mimic other 
blistering disorders, such as bullous pemphigoid, dermatitis herpetiformis, and SJS/TEN. In 
drug-induced LAD, the onset of blisters usually occurs within 7–15 days after beginning of 
drug use with a mean onset of 8 days and resolution within 2–7 weeks upon drug 
withdrawal.[Nousari, et al., 1999] Circulating IgA-antibodies are found in less than 40% of 
cases.[Nousari, et al., 1999] Antigenic targets are heterogeneous.[Wojnarowska, et al., 1999] 
Patient’s sera react against the basement membrane similar to the pattern observed with 
antibodies to the hemidesmosome components, the alpha6beta4 integrin and the bullous 
pemphigoid antigens BP230 and BP180, 255-kD and 285-kD proteins as well as collagen 
VII.[Wojnarowska, et al., 1999]  
7.2 Histology 
Histologically, LAD shows subepidermal blisters most often with an infiltrate primarily 
consisting of neutrophils (figures 13C and 13D). As much as clinically, LAD is variable 
histopathologically, resembling bullous pemphigoid, dermatitis herpetiformis, or 
epidermolysis bullosa aquisita. Even LAD under the clinical picture of SJS/TEN has been 
reported.[Schneck, et al., 1999] Direct immunofluorescence of perilesional skin shows linear 
deposition of IgA along the basement membrane zone, usually in a homogenous pattern 
(figure 13E). Examples of granular linear deposition at the BMZ have also been 
identified.[Kuechle, et al., 1994] In addition, C3 deposition at the BMZ is also found on 
occasion.[Kuechle, et al., 1994] 
7.3 Differential diagnoses histopathologically 
The diagnosis of LAD cannot be made exclusively based on histopathology. Clinical data as 
well a results form direct and indirect immunofluorescence have to be considered. 
Differentiation has to be made in particular from bullous pemphigoid, dermatitis 
herpetiformis, and epidermolysis bullosa aquisita. 
8. Principles and techniques of skin biopsies in drug eruptions  
[Ackerman, et al., 2005, Weyers and Diaz, 2002] 
In patients with severe skin reactions, a skin biopsy should be taken whenever  
possible. The clinician is obliged to present rudimentary information to the 
dermatohistopathologist. In several instances histopathologic diagnosis is impossible 
without any clinical information. Such information is: age and gender of the patient, 
duration of the disease/biopsied lesion, distribution, configuration and arrangement of 
lesions, morphology of the individual lesion, localization and type of biopsy, suggested 
clinical diagnosis and differential diagnosis. The skin biopsy itself follows an essential 
sequence beginning with the selection of one or more lesions for biopsy, sampling of the 
tissue with optimal technique, correct fixation of the tissue and finally the accurate 
histopathologic diagnosis.  
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                                      (a)                                                                (b) 
  
(c)                                                               (d) 
 
(e) 
Fig. 13. A and B: Tense blisters with a linear or annular arrangement on erythematous but 
mostly normal appearing skin. 
C and D: Subepidermal blisters with an infiltrate of neutrophilic and eosinophilic 
granulocytes (B: hematoxylin-eosin, original magnification x40, C: hematoxylin-eosin, 
original magnification x200). 
E: Direct immunofluorescence of perilesional skin with linear homogenous deposition of 
IgA along the basement membrane zone (original magnification x200). 
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The very-first criterion for the selection of the biopsy-site is the appearance of the 
efflorescence. As a general rule, biopsies should not be performed from excoriated or 
scarred lesions, and postinflammatory pigmentary changes. Those, in most instances, do not 
provide enough information for evaluation of the nature of the underlying inflammatory 
process. Preferentially, a fresh primary lesion should be selected, without secondary 
changes. Such are: macules and papules (papules are preferred to macules), papulovesicles, 
vesicles or pustules. If similar lesions are present on the legs and elsewhere, the biopsy 
should not be taken from the legs below the knee. In the latter localization changes could be 
superimposed by stasis dermatitis, complicating the correct histopathologic diagnosis. The 
biopsy should be performed in the most inflamed area. In some situations it could be 
helpful to take several or sequential biopsies, in particular if primary lesions are present in 
different stages of evolution. In cases of vesicular or bullous lesions or even widespread 
epidermolysis the biopsy should be performed at the periphery of the blister/bulla 
including larger parts of the surrounding erythema. A biopsy from the blister itself or from 
the surrounding of older blisters has to be avoided. If the biopsy is taken from the blister 
itself, the roof of the blister usually gets lost and consequently is not available for 
histopathologic evaluation. However, even if present, the blister roof is mostly already 
totally necrotic. Moreover, direct immunofluorescence (where necessary for differential 
diagnosis) from the blister itself gives false negative results. Furthermore, older blisters are 
often contaminated with bacteria, show signs of re-epithelialization and again do not allow 
for direct immunofluorescence. In most instances a punch biopsy is adequate. The biopsy 
punch is penetrated up to the subcutaneous adipose tissue. The dermis easily separates from 
the subcutis and the tissue cylinder can be removed gently (to avoid squeezing artefacts) 
with anatomic forceps. The resulting defect is in most instances closed with a simple suture. 
A sufficient size (advised are at least 6mm) of the biopsy punch has to be chosen. It has to be 
kept in mind that subsequent formalin fixation and paraffin embedding reduce the tissue-
volume up to one third. Alternatively an excision biopsy with a scalpel can be performed. In 
particular, biopsies from bullous skin diseases have, apart from tiny tense vesicles, to be 
performed with a scalpel since a punch biopsy leads to the loss of the epidermis. Shave 
biopsies are inadequate. A shave in general is not a proper technique for biopsy of 
inflammatory dermatoses. Moreover, histopathologic analysis of a biopsy taken from a 
blister only does not allow the various types of reaction to be distinguished. After removal 
of the specimen it should be added to a fixative solution. The common fixative for skin 
tissue is 4 % or 10 % buffered formalin (formaldehyde). The amount of formalin should 
excess the volume of the specimen by about 20times. Before further technical preparation, 
the specimen should be kept in formalin at least for several hours to obtain optimal fixation. 
No refrigeration is needed. Formalin is inappropriate as transport medium for direct 
immunofluorescence. Diverse electrolyte solutions have been suggested for 
immunofluorescence and vary in laboratories of different countries (e.g. Michel´s medium; 
isotonic sodium chloride solution; or a ready-to-use ‘electrolyte solution 77 with glucose 5’, 
Serumwerk Bernburg AG; Germany). In the vast majority of cases histopathologic diagnosis 
is based on a few hematoxylin & eosin sections. Slides should be systematically screened in 
all its layers. Further histochemical stainings (such as periodic-acid-Schiff (PAS), Masson 
Fontana, Giemsa) are usually not necessary, but can be helpful for differential diagnosis. 
Immunhistochemical stainings are not routinely performed. Immunhistochemical stainings, 
using polyclonal or monoclonal antibodies binding specifically to tissue antigens, may be of 
scientific interest concerning CD-antigens or antibodies against cytokines or cytokine 
receptors. If differential diagnosis includes autoimmune bullous skin disorders, 
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immunofluorescence should be performed and an additional biopsy specimen (or part of a 
biopsy) should be taken for direct immunofluorescence. Direct immunofluorescence uses 
single antibodies which are chemically linked to a fluorophore which can be detected via 
microscope. Routinely, IgG, IgM, IgA, complement factors (C3) and fibrin are used to detect 
intra- and subepidermal, basal membrane zone, or perivascular depositions. These may be 
helpful in differentiating bullous drug eruption from primarily autoimmune-blistering 
diseases, such as bullous pemphigoid or pemphigus. In particular, this can be of importance 
in diagnosing drug-induced linear-IgA-dermatosis. For sampling of tissue for direct 
immunofluorescence the following has to be considered: a biopsy for direct 
immunofluorescence is more suitable from direct perilesional skin. The biopsy of a blister 
itself has to be avoided.  
Sine qua non, however, prior to any sophisticated technique, is a close contact to the 
clinician and whenever possible a clinical-histopathologic correlation. In case direct 
consultation of the patient is not possible, means of teledermatology can be used. 
Dermatology is ideally suited for telemedicine techniques, as has been shown in a number 
of recent studies investigating feasibility and reliability of teledermatology.[Massone, et al., 
2008] It has generally demonstrated high levels of concordance in diagnoses compared with 
face-to-face consultations. Moreover, the implementation of virtual slide systems for 
teledermatopathology has allowed avoiding the limitations imposed by conventional 
microphotography.[Massone, et al., 2008] 
9. Conclusion 
Severe cutaneous adverse reactions - mainly related to drugs - include several distinct 
clinical entities. Within the past decades enormous endeavor has been made to clinically 
classify SJS, TEN and transitional forms and separate them clinically from EMM. In 
addition, new disease entities have been described, among them AGEP and DRESS, 
formerly referred to as hypersensitivity syndrome. GBFDE has been recognized as a severe 
form of the well known localized fixed drug eruption. In clinical terms, for all those entities 
substantiated classification criteria have been developed and established in clinical practice. 
However, despite all these efforts, some diagnostic gaps still exist from a histopathologic 
point of view. This is based on the fact that several entities of severe cutaneous adverse 
reactions have histopathologic features in common, impeding the exact separation among 
each other. In addition, superficially or insufficiently performed biopsies complicate the 
diagnosis. Generally accepted standards of biopsy and sample processing including 
(additional) stainings or techniques are still missing. Histopathologic assessment and report 
of findings is still arbitrary with many inter-observer variations. Since all named entities are 
quite rare, the quality of histopathologic assessment depends mainly on the experience of 
the histopathologist. Besides this, difficulties may occur in differentiation of severe 
cutaneous adverse reactions from unrelated inflammatory skin diseases.   
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